guanabenz has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donia, AA; El Tokhy, SS; Haggag, YA; Isreb, M; Tambuwala, MM; Yasser, M | 1 |
| Hamamura, K; Koizumi, M; Matsuura, N; Minami, K; Na, S; Tanjung, N; Wan, Q; Yokota, H | 1 |
2 other study(ies) available for guanabenz and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer.
Topics: Animals; Cell Line, Tumor; Drug Repositioning; Guanabenz; Humans; Mice; Tissue Distribution; Triple Negative Breast Neoplasms | 2021 |
Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cinnamates; Dose-Response Relationship, Drug; Eukaryotic Initiation Factor-2; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Guanabenz; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; rac1 GTP-Binding Protein; Signal Transduction; Thiourea; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2014 |